Morepen Laboratories Limited (MOREPENLAB.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 20.4B |
| Enterprise Value | 21.79B |
| P/E Ratio | 52.19 |
| PEG Ratio | 1.01 |
| Price/Sales Ratio | 3.75 |
| Price/Book Ratio | 5.87 |
| Enterprise/Revenue | 3.75 |
| Enterprise/EBITDA | 32.29 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.08 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 18.06B |
| Revenue/Share | 35.6 |
| Gross Profit | 6.82B |
| EBITDA | 1.73B |
| Net Income | 948.77M |
| Diluted EPS | 1.73 |
Balance Sheet
| Total Cash | 916.99M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 22.76 |
Price History
| 52-Week Change | 171.38 |
| 52-Week High | 135.29 |
| 52-Week Low | 33.05 |
| Moving Average 50 Days | 97.18 |
| Moving Average 200 Days | 56.96 |
Statistics
| Average Volume | 21.62M |
| Shares Outstanding | 547.95M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.2 |
| Trailing Annual Dividend Yield | 0.15 |
| Payout Ratio | 0.08 |
| Last Split Factor | 5:1 |
| Last Split Date | November 07, 2000 |
AD
